Sharma C, Kumar N, Pandey R, Meis J F, Chowdhary A
Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Wellcome Trust Sanger Institute, Hinxton, UK.
New Microbes New Infect. 2016 Jul 29;13:77-82. doi: 10.1016/j.nmni.2016.07.003. eCollection 2016 Sep.
Candida auris is an emerging multidrug resistant yeast that causes nosocomial fungaemia and deep-seated infections. Notably, the emergence of this yeast is alarming as it exhibits resistance to azoles, amphotericin B and caspofungin, which may lead to clinical failure in patients. The multigene phylogeny and amplified fragment length polymorphism typing methods report the C. auris population as clonal. Here, using whole genome sequencing analysis, we decipher for the first time that C. auris strains from four Indian hospitals were highly related, suggesting clonal transmission. Further, all C. auris isolates originated from cases of fungaemia and were resistant to fluconazole (MIC >64 mg/L).
耳念珠菌是一种新出现的多重耐药酵母,可引起医院获得性真菌血症和深部感染。值得注意的是,这种酵母的出现令人担忧,因为它对唑类、两性霉素B和卡泊芬净具有耐药性,这可能导致患者临床治疗失败。多基因系统发育和扩增片段长度多态性分型方法表明耳念珠菌群体为克隆性。在此,我们通过全基因组测序分析首次破译,来自印度四家医院的耳念珠菌菌株高度相关,提示存在克隆传播。此外,所有耳念珠菌分离株均源自真菌血症病例,且对氟康唑耐药(MIC>64mg/L)。